Impact of empiric antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) infection and associated Clostridioides difficile infection (CDI) risk: Secondary analysis of the CLEAR trial.
Infect Control Hosp Epidemiol
; 42(12): 1493-1496, 2021 12.
Article
em En
| MEDLINE
| ID: mdl-33858553
ABSTRACT
We performed secondary analyses of a postdischarge decolonization trial of MRSA carriers that reduced MRSA infection and hospitalization by 30%. Hospitalized MRSA infection was associated with 7.9 days of non-MRSA antibiotics and CDI in 3.9%. Preventing MRSA infection and associated hospitalization may reduce antibiotic use and CDI incidence.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Infecções Estafilocócicas
/
Infecção Hospitalar
/
Infecções por Clostridium
/
Staphylococcus aureus Resistente à Meticilina
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article